BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9315656)

  • 1. SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.
    Sumi-Ichinose C; Ichinose H; Metzger D; Chambon P
    Mol Cell Biol; 1997 Oct; 17(10):5976-86. PubMed ID: 9315656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).
    Reyes JC; Barra J; Muchardt C; Camus A; Babinet C; Yaniv M
    EMBO J; 1998 Dec; 17(23):6979-91. PubMed ID: 9843504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells.
    Chiba H; Clifford J; Metzger D; Chambon P
    J Cell Biol; 1997 Nov; 139(3):735-47. PubMed ID: 9348290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling.
    Rochette-Egly C; Chambon P
    Histol Histopathol; 2001 Jul; 16(3):909-22. PubMed ID: 11510982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.
    Chiba H; Muramatsu M; Nomoto A; Kato H
    Nucleic Acids Res; 1994 May; 22(10):1815-20. PubMed ID: 8208605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.
    Clifford J; Chiba H; Sobieszczuk D; Metzger D; Chambon P
    EMBO J; 1996 Aug; 15(16):4142-55. PubMed ID: 8861943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant negative retinoid X receptor beta inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells.
    Minucci S; Zand DJ; Dey A; Marks MS; Nagata T; Grippo JF; Ozato K
    Mol Cell Biol; 1994 Jan; 14(1):360-72. PubMed ID: 8264603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene.
    Thompson JR; Gudas LJ
    Mol Cell Endocrinol; 2002 Sep; 195(1-2):119-33. PubMed ID: 12354678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells.
    Chiba H; Clifford J; Metzger D; Chambon P
    Mol Cell Biol; 1997 Jun; 17(6):3013-20. PubMed ID: 9154799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain.
    Bourachot B; Yaniv M; Muchardt C
    Mol Cell Biol; 1999 Jun; 19(6):3931-9. PubMed ID: 10330133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
    Roy B; Taneja R; Chambon P
    Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F inhibits transcriptional activation by the retinoic acid receptor.
    Costa SL; Pratt MA; McBurney MW
    Cell Growth Differ; 1996 Nov; 7(11):1479-85. PubMed ID: 8930397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes.
    Wang W; Chi T; Xue Y; Zhou S; Kuo A; Crabtree GR
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):492-8. PubMed ID: 9435219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers.
    Segars JH; Nagata T; Bours V; Medin JA; Franzoso G; Blanco JC; Drew PD; Becker KG; An J; Tang T
    Mol Cell Biol; 1993 Oct; 13(10):6157-69. PubMed ID: 8413217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SWI/SNF complex and cancer.
    Reisman D; Glaros S; Thompson EA
    Oncogene; 2009 Apr; 28(14):1653-68. PubMed ID: 19234488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.
    Heim KC; White KA; Deng D; Tomlinson CR; Moore JH; Freemantle SJ; Spinella MJ
    Mol Cancer; 2007 Sep; 6():57. PubMed ID: 17880687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
    Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
    Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a retinoic acid-inducible element in the murine PTH/PTHrP (parathyroid hormone/parathyroid hormone-related peptide) receptor gene.
    Karperien M; Farih-Sips H; Hendriks JA; Lanske B; Papapoulos SE; Abou-Samra AB; Löwik CW; Defize LH
    Mol Endocrinol; 1999 Jul; 13(7):1183-96. PubMed ID: 10406468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.